The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC).
 
Winston Wong
No Relationships to Disclose
 
Jennifer R. Cracchiolo
No Relationships to Disclose
 
Nadeem Riaz
Honoraria - PeerView
Consulting or Advisory Role - Mirati Therapeutics; Repare Therapeutics
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Paige.AI; Pfizer; Repare Therapeutics
Travel, Accommodations, Expenses - Varian Medical Systems
 
Ian Ganly
No Relationships to Disclose
 
Eric Jeffrey Sherman
Consulting or Advisory Role - Blueprint Medicines; Eisai; Exelixis; Lilly; UpToDate
Research Funding - HUTCHMED (Inst); Lilly (Inst); Novartis (Inst); Plexxikon (Inst); Regeneron (Inst)
 
Alan Loh Ho
Stock and Other Ownership Interests - Rgenta
Honoraria - Endocrine Society; Physicans' Education Resource
Consulting or Advisory Role - AffyImmune Therapeutics; Ayala Pharmaceuticals; Cellestia Biotech; Eisai; Eisai; Elevar Therapeutics; Exelixis; ExpertConnect; InxMed; Kura Oncology; Merck; Prelude Therapeutics; Remix Therapeutics; Rgenta
Research Funding - Astellas Pharma; AstraZeneca; Ayala Pharmaceuticals; Bayer; Bayer; Bristol-Myers Squibb; Eisai; Elevar Therapeutics; Elevar Therapeutics; Genentech/Roche; Kura Oncology; Merck; Novartis
Patents, Royalties, Other Intellectual Property - LESIONAL DOSIMETRY METHODS FOR TAILORING TARGETED RADIOTHERAPY IN
 
Luc Morris
Patents, Royalties, Other Intellectual Property - I am an inventor on IP owned by Memorial Sloan Kettering Cancer Center and licensed to PGDx
 
Ronald A Ghossein
No Relationships to Disclose
 
Sofia Haque
Honoraria - Advanced Medical
Consulting or Advisory Role - Advanced Medical
 
Kin Wai (Tony) Hung
Stock and Other Ownership Interests - TeamX Medical Group
Patents, Royalties, Other Intellectual Property - LookUpTrials - Patent pending
 
Anuja Kriplani
No Relationships to Disclose
 
Marc Cohen
No Relationships to Disclose
 
Jay Boyle
No Relationships to Disclose
 
Sean Matthew McBride
Consulting or Advisory Role - AstraZeneca; Janssen
Research Funding - AstraZeneca; Genentech
 
Daphna Y. Gelbum
No Relationships to Disclose
 
Loren S. Michel
Consulting or Advisory Role - KisoJi Biotechnology
Research Funding - Exelixis (Inst)
(OPTIONAL) Uncompensated Relationships - Abbvie
 
Nancy Y. Lee
Consulting or Advisory Role - Merck; Merck Serono; Mirati Therapeutics; Pfizer; Roche/Genentech; Sanofi
Research Funding - AstraZeneca; Pfizer (Inst)
 
Richard J. Wong
No Relationships to Disclose
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim; Incyte; MeiraGTx; Nykode Therapeutics
Research Funding - AstraZeneca (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Hookipa Pharma (Inst); Lilly (Inst); MedImmune (Inst); MeiraGTx (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)
 
Lara Dunn
Consulting or Advisory Role - Merck
Research Funding - CUE Biopharma; Nektar; Regeneron; Replimune; Seagan; Seagan